Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination
Open Access
- 11 May 2021
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 325 (18), 1896-1898
- https://doi.org/10.1001/jama.2021.4388
Abstract
Serum neutralizing antibodies rapidly appear after SARS-CoV-2 infection1 and vaccination2 and are maintained for several months.3,4 The emergence of SARS-CoV-2 variants has raised concerns about the breadth of neutralizing-antibody responses. We compared the neutralizing-antibody response to 4 variants in infected and vaccinated individuals to determine how mutations within the spike protein are associated with virus neutralization.Keywords
This publication has 6 references indexed in Scilit:
- Neutralizing Activity of BNT162b2-Elicited SerumThe New England Journal of Medicine, 2021
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionScience, 2021
- Durability of Responses after SARS-CoV-2 mRNA-1273 VaccinationThe New England Journal of Medicine, 2021
- Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS‐CoV‐2 Neutralizing AntibodiesCurrent Protocols in Immunology, 2020
- An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportThe New England Journal of Medicine, 2020
- Rapid Generation of Neutralizing Antibody Responses in COVID-19 PatientsCell Reports Medicine, 2020